Barclays’s Harte-Hanks HHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $11.7K | Buy |
2,580
+2,578
| +128,900% | +$8.79K | ﹤0.01% | 4818 |
|
|
2026
Q2 | $4 | Buy |
+2
| New | +$5 | ﹤0.01% | 5310 |
|
|
2025
Q4 | – | Sell |
-87
| Closed | -$323 | – | 5414 |
|
|
2025
Q3 | $323 | Buy |
+87
| New | +$314 | ﹤0.01% | 5223 |
|
|
2020
Q3 | – | Sell |
-7
| Closed | – | – | 5345 |
|
|
2020
Q2 | $0 | Buy |
+7
| New | +$17 | ﹤0.01% | 5832 |
|
|
2019
Q4 | – | Sell |
-127
| Closed | – | – | 6537 |
|
|
2019
Q3 | $0 | Buy |
+127
| New | +$400 | ﹤0.01% | 6870 |
|
|
2018
Q4 | – | Sell |
-22
| Closed | – | – | 7091 |
|
|
2018
Q3 | $0 | Buy |
+22
| New | +$193 | ﹤0.01% | 7232 |
|
|
2018
Q2 | – | Sell |
-33
| Closed | – | – | 7077 |
|
|
2018
Q1 | $0 | Buy |
33
+28
| +560% | +$256 | ﹤0.01% | 7167 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 6993 |
|
|
2017
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 6921 |
|
|
2017
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 6756 |
|
|
2017
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6838 |
|
|
2016
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 6698 |
|
|
2016
Q3 | $0 | Sell |
5
-570
| -99% | -$9.39K | ﹤0.01% | 6683 |
|
|
2016
Q2 | $9K | Buy |
575
+570
| +11,400% | +$10.1K | ﹤0.01% | 5575 |
|
|
2016
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6250 |
|
|
2015
Q4 | $0 | Sell |
5
-43
| -90% | -$1.61K | ﹤0.01% | 6209 |
|
|
2015
Q3 | $2K | Sell |
48
-50
| -51% | -$2.26K | ﹤0.01% | 6333 |
|
|
2015
Q2 | $4K | Sell |
98
-55
| -36% | -$3.7K | ﹤0.01% | 6557 |
|
|
2015
Q1 | $10K | Sell |
153
-133
| -47% | -$10.3K | ﹤0.01% | 6222 |
|
|
2014
Q4 | $20K | Sell |
286
-215
| -43% | -$14.1K | ﹤0.01% | 6325 |
|
|
2014
Q3 | $29K | Buy |
501
+228
| +84% | +$15.5K | ﹤0.01% | 6245 |
|
|
2014
Q2 | $19K | Sell |
273
-64
| -19% | -$4.94K | ﹤0.01% | 6530 |
|
|
2014
Q1 | $26K | Buy |
337
+24
| +8% | +$1.87K | ﹤0.01% | 6450 |
|
|
2013
Q4 | $22K | Sell |
313
-2,462
| -89% | -$201K | ﹤0.01% | 6657 |
|
|
2013
Q3 | $222K | Sell |
2,775
-2,126
| -43% | -$195K | ﹤0.01% | 4938 |
|
|
2013
Q2 | $421K | Buy |
+4,901
| New | +$406K | ﹤0.01% | 4414 |
|
Other funds holding HHS
JC
CL
Barclays's HHS Position: Q3 2026 in Review
Barclays increased its Harte-Hanks (HHS) stake by 128,900% in Q3 2026, buying an estimated $8.79K and bringing the position to 2,580 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4818.
Barclays first reported a position in HHS in Q2 2013 and has held it in 26 quarters since. The position peaked at $421K in Q2 2013. 31 funds tracked by Wall St. Rank hold HHS as of Q3 2026.
- Barclays held 2,580 shares of Harte-Hanks worth $11.7K as of Q3 2026.
- Barclays bought 2,578 Harte-Hanks shares in Q3 2026, an estimated $8.79K.
- Harte-Hanks made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4818 holding.
- Barclays first reported a position in Harte-Hanks in Q2 2013 and has held it in 26 quarters since.
- Barclays's Harte-Hanks position peaked at $421K in Q2 2013.
- 31 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.